List of DETROIT R & D, INC. patents

List of DETROIT R & D, INC. patents

List of Whisker Labs patents

List of HyTrust patents

List of Wrap Media patents

List of companies in Peacock Equity's investment portfolio

Investors in Syndicate

Patents where

Current Assignee

Name

is

‌

DETROIT R & D, INC.

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 11519922 Methods for identifying risk of chemotherapy-induced cardiotoxicity and targeted medical intervention			‌ DETROIT R & D, INC.		United States Patent and Trademark Office	11519922	December 6, 2022
	‌ US Patent 7695927 Detection of hypertension using glucuronidated metabolic products	Patent 7695927 was granted and assigned to DETROIT R & D, INC. on April, 2010 by the United States Patent and Trademark Office.		‌ DETROIT R & D, INC.		United States Patent and Trademark Office	7695927	April 13, 2010
	‌ US Patent 8765641 Chip production, hybridization and data interpretation for antibody and protein microarrays	Patent 8765641 was granted and assigned to DETROIT R & D, INC. on July, 2014 by the United States Patent and Trademark Office.		‌ DETROIT R & D, INC.		United States Patent and Trademark Office	8765641	July 1, 2014
	‌ US Patent 9212221 Form-specific antibodies for NAG-1 (MIC-1, GDF-15), H6D and other TGF-β subfamily and heart disease and cancer diagnoses	Patent 9212221 was granted and assigned to DETROIT R & D, INC. on December, 2015 by the United States Patent and Trademark Office.		‌ DETROIT R & D, INC.		United States Patent and Trademark Office	9212221	December 15, 2015
	‌ US Patent 10317409 Glycosylation site-specific antibodies and anti-cancer compounds	Patent 10317409 was granted and assigned to DETROIT R & D, INC. on June, 2019 by the United States Patent and Trademark Office.		‌ DETROIT R & D, INC.		United States Patent and Trademark Office	10317409	June 11, 2019
	‌ US Patent 7202226 Augmentation of wound healing by elF-4E mRNA and EGF mRNA	Patent 7202226 was granted and assigned to DETROIT R & D, INC. on April, 2007 by the United States Patent and Trademark Office.		‌ DETROIT R & D, INC.		United States Patent and Trademark Office	7202226	April 10, 2007
	‌ US Patent 8409821 Detection of hypertension using glucuronidated metabolic products	Patent 8409821 was granted and assigned to DETROIT R & D, INC. on April, 2013 by the United States Patent and Trademark Office.		‌ DETROIT R & D, INC.		United States Patent and Trademark Office	8409821	April 2, 2013

7 results

0 selected

7 results

0 selected